Logos Global Management LP 13D/13G Filings for Dyne Therapeutics, Inc. (DYN)

Logos Global Management LP 13D and 13G filings for Dyne Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
3:53 pm
Sale		 2022-12-31 13G Dyne Therapeutics, Inc.
DYN		 Logos Global Management LP 2,150,000
4.100%		 -804,392decrease
(-27.23%)		 Filing
2022-02-14
4:10 pm
Sale		 2021-12-31 13G Dyne Therapeutics, Inc.
DYN		 Logos Global Management LP 2,954,392
5.700%		 -940,000decrease
(-24.14%)		 Filing
2021-08-16
2:37 pm
Purchase		 2021-08-05 13G Dyne Therapeutics, Inc.
DYN		 Logos Global Management LP 3,894,392
7.600%		 3,894,392increase
(New Position)		 Filing